Further analysis of the flow profiles using standard gating approaches demonstrated that in 2/4 controls, approximately 30% of CD8α+, TRCβhi, NK1.1− T cells were positive for PD-1, the other two were similar to the treated tumours and >90% strongly PD-1 positive (Figure 5E). The gene discussed is CD8A; the disease is neoplasm.